81
/ 100
True
Europe
The text discusses the ongoing investigation by the European prosecutor’s office into the procurement of COVID-19 vaccines for EU countries, focusing on Ursula von der Leyen's role and the lack of transparency in the process.
Infact verdict: True (81/100).
The investigation into the procurement of COVID-19 vaccines by the European prosecutor’s office is confirmed by multiple sources, indicating concerns over transparency. Ursula von der Leyen has not provided personal testimony in this investigation, as corroborated by reliable sources. Negotiations with Pfizer CEO Albert Bourla did precede a significant vaccine deal, although details remain unclear. The EU Court ruled against the European Commission for denying access to von der Leyen’s correspondence with Pfizer, highlighting transparency issues. The European Commission's claim that the correspondence was not preserved is supported by reports of phone replacements and data formatting.
How is this score determined? →Individual claims
91
True
World
The European prosecutor’s office is investigating the procurement of COVID-19 vaccines for EU countries.
The European Public Prosecutor's Office has confirmed an ongoing investigation into the procurement of COVID-19 vaccines for EU countries. This is corroborated by multiple reliable sources, including Barron's and Fierce Pharma.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
90
Web Consensus Weight
40
Source Quality Score
85
Source Quality Weight
20
Llm Reasoning Score
80
Llm Reasoning Weight
40
Llm Reasoning Score Raw
80
Weighted Total
91
Evidence Summary
Multiple reliable sources confirm the investigation.
88
True
World
Ursula von der Leyen has not given personal testimony in the investigation.
Reliable sources such as Politico confirm that Ursula von der Leyen has not provided personal testimony in the investigation by the European Public Prosecutor’s Office.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
85
Web Consensus Weight
40
Source Quality Score
80
Source Quality Weight
20
Llm Reasoning Score
75
Llm Reasoning Weight
40
Llm Reasoning Score Raw
75
Weighted Total
88
Evidence Summary
Reliable sources confirm von der Leyen has not testified.
66
Mostly True
Business
Negotiations with Pfizer CEO Albert Bourla preceded a multibillion-dollar vaccine deal.
Sources indicate that negotiations with Pfizer CEO Albert Bourla preceded a significant vaccine deal, although specific details are not fully clear. This is supported by Influence Watch and Wikipedia.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
70
Web Consensus Weight
40
Source Quality Score
75
Source Quality Weight
20
Llm Reasoning Score
70
Llm Reasoning Weight
40
Llm Reasoning Score Raw
70
Weighted Total
66
Evidence Summary
Negotiations with Pfizer CEO confirmed by multiple sources.
94
True
World
The EU Court ruled that the European Commission unjustifiably denied access to von der Leyen’s correspondence with the Pfizer CEO.
The General Court of the European Union ruled that the European Commission violated transparency laws by denying access to von der Leyen's correspondence with Pfizer CEO Albert Bourla. This is confirmed by Access Info Europe and Le Monde.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
95
Web Consensus Weight
40
Source Quality Score
90
Source Quality Weight
20
Llm Reasoning Score
85
Llm Reasoning Weight
40
Llm Reasoning Score Raw
85
Weighted Total
94
Evidence Summary
EU Court ruling confirmed by multiple high-quality sources.
65
Mostly True
World
The European Commission stated that the correspondence with Pfizer CEO had not been preserved.
The European Commission's statement that the correspondence with Pfizer CEO was not preserved is supported by reports from The New York Times and PBS News, citing phone replacements and data formatting.
Fact Check Score
None
Fact Check Weight
0
Web Consensus Score
75
Web Consensus Weight
40
Source Quality Score
70
Source Quality Weight
20
Llm Reasoning Score
65
Llm Reasoning Weight
40
Llm Reasoning Score Raw
65
Weighted Total
65
Evidence Summary
Commission's statement confirmed by multiple sources.
